Investment Summary |
|
|---|---|
| Date | 2019-12-23 |
| Target | InformedDNA |
| Sector | Life Science |
| Investor(s) |
TT Capital Partners
NovaQuest QHP Capital |
| Deal Type | Growth Capital |
| Advisor(s) | Robert W. Baird & Co., Inc. (Financial) Foley & Lardner (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
TT Capital Partners is the investment arm of financial advisory firm TripleTree. TT Capital Partners invests in emerging healthcare technology and services companies with the potential to be market leaders across disruptive themes in healthcare. TT Capital Partners is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 15 |
| Sector (Life Science) | 1 of 1 |
| Type (Growth Capital) | 5 of 9 |
| State (Florida) | 1 of 1 |
| Country (United States) | 7 of 14 |
| Year (2019) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-04 |
Softheon
Stony Brook, New York, United States Softheon is a cloud-based eligibility, enrollment, and billing provider for health plans and government agencies. Softheon's Software-as-a-Service (SaaS) and Business Process-as-a-Service (BPaaS) solutions solve complex challenges for health plans and government health agencies. Softheon was founded in 2000 and is based in Stony Brook, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-04-10 |
Integra ServiceConnect
Owings Mills, Maryland, United States Integra represents a quarter of the combined company revenue and addresses the social needs of its members with operations in multiple states. Integra operates its existing business while leveraging its expertise to help MedZed engage more members in its existing markets. Integra’s Community Health Worker engagement model which has yielded high success rates compared to traditional remote outreach methods will be implemented with MedZed’s existing customers enabling increased engagement and retention rates of referred Medicaid members. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2010 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
NovaQuest Capital Management is a private equity firm focused on acquiring and investing in growth-stage middle-market healthcare companies. Specific areas of interest include life science, medical technology, healthcare/facility services, and healthcare focused IT. The Firm targets profitable companies valued up to $500 million with $20 to $100 million of revenue. NovaQuest Capital Management was established in 2000 and is based in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 14 |
| Sector (Life Science) | 6 of 8 |
| Type (Growth Capital) | 2 of 5 |
| State (Florida) | 1 of 2 |
| Country (United States) | 7 of 11 |
| Year (2019) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-06-18 |
Nevakar
Bridgewater, New Jersey, United States Nevakar is a fully integrated specialty pharmaceutical company with an extensive portfolio of products in the ophthalmic and injectable areas. Nevakar was founded in 2015 and is based in Bridgewater, New Jersey. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-04 |
Clinical Ink
Horsham, Pennsylvania, United States Clinical Ink is a clinical technology company that offers data certainty from source to submission. The company's Lumenis eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source naturally enhances clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as trials progress. Clinical Ink was founded in 2007 and is based in Horsham, Pennsylvania. |
Sell | - |
QHP Capital is a private equity firm focused on healthcare businesses in the middle-market. Specific areas of interest include tech-enabled life sciences and pharma service companies. The Firm seeks to partner with management teams in founder or family-owned companies, and invests in buyouts and other transaction types. QHP Capital was founded in 2022 and is headquartered in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 11 |
| Sector (Life Science) | 2 of 5 |
| Type (Growth Capital) | 1 of 3 |
| State (Florida) | 1 of 3 |
| Country (United States) | 3 of 11 |
| Year (2019) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-31 |
Catalyst Clinical Research
Wilmington, North Carolina, United States Catalyst Clinical Research is a provider of staffing resources to the biotechnology, pharmaceutical and medical device companies for clinical trial needs. Catalyst Clinical Research was founded in 2013 and is based in Wilmington, North Carolina. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-04 |
Clinical Ink
Horsham, Pennsylvania, United States Clinical Ink is a clinical technology company that offers data certainty from source to submission. The company's Lumenis eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source naturally enhances clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as trials progress. Clinical Ink was founded in 2007 and is based in Horsham, Pennsylvania. |
Buy | - |
